Values of the Immune Activation Markers CD38 and HLA-DR and the Ratio CD4/CD8 According to the Delay of Combined AntiRetroviral Therapy (c-ART) Initiation in Primary HIV-infected Patients (PRIMIMMUNO)

NCT02827227 · clinicaltrials.gov ↗
COMPLETED
Status
99
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Hospices Civils de Lyon